FMP
Affluent Medical SA
AFME.PA
EURONEXT
Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.
1.76 EUR
-0.04 (-2.27%)
About
ceo
Sebastien Ladet Ph.D.
sector
Healthcare
industry
Medical - Devices
website
https://www.affluentmedical.com
exchange
EURONEXT
Description
Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.
CIK
N/A
ISIN
FR0013333077
CUSIP
N/A
Address
320, avenue Archimède
Phone
33 4 42 95 12 20
Country
FR
Employee
52
IPO Date
Jun 14, 2021
Summary
CIK
-
Exchange
EURONEXT
Industry
Medical - Devices
Sector
Healthcare
CUSIP
-
ISIN
FR0013333077
Country
FR
Price
1.76
Beta
0.5
Volume Avg.
10.8k
Market Cap
58.34M
Shares
-
52-Week
0.93-2.3
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-2.71
P/B
-
Website
https://www.affluentmedical.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest AFME.PA News
It looks like there's no news available.
